JP Patent

JP2017528499A — 肝臓の疾患を治療するためのオメガ３脂肪酸とｓｇｌｔ−２阻害薬との併用剤

Assigned to AstraZeneca AB · Expires 2017-09-28 · 9y expired

What this patent protects

ＮＡＦＬＤ及び／又はＮＡＳＨの治療方法及びこの方法の実施に好適な組成物が特許請求される。

USPTO Abstract

ＮＡＦＬＤ及び／又はＮＡＳＨの治療方法及びこの方法の実施に好適な組成物が特許請求される。

Drugs covered by this patent

Patent Metadata

Patent number
JP2017528499A
Jurisdiction
JP
Classification
—
Expires
2017-09-28
Drug substance claim
No
Drug product claim
No
Assignee
AstraZeneca AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.